Thanks 123, L/T holders now have to face up to TIS going it alone, which is what they should have been preparing for all along. This was a management debacle, as you said. Now we should be told how much they have prepared for this event. Will they get back to their basic goals of selling high volume over-the-counter treatments as the inventors desired, or still persist in big noting themselves into performing a lesser number of miracles on the world stage. Can't say much more in anger, because I'm a too big L/T holder. Godonyer, Japes.
TIS Price at posting:
54.0¢ Sentiment: Hold Disclosure: Held